Literature DB >> 2541430

Antibodies specific to the retinoic acid human nuclear receptors alpha and beta.

M P Gaub1, Y Lutz, E Ruberte, M Petkovich, N Brand, P Chambon.   

Abstract

Two cDNAs encoding two human receptors for retinoic acid (RA), RAR-alpha and RAR-beta, have been characterized recently. Synthetic peptides corresponding to the cDNA-deduced amino acid sequences unique to RAR-alpha and RAR-beta were used to generate anti-RAR-alpha antiserum (SP171) and anti-RAR-beta antisera (SP172 and SP248). The specificity of these antisera was confirmed both by immunocytochemical detection of these receptors in COS-1 cells transfected with RAR-alpha and RAR-beta expression vectors and by immunoblot analyses performed with whole extracts of these cells. We also demonstrate that these antisera recognize RAR-alpha and RAR-beta endogenously expressed in the RA-responsive human promyelocytic leukemia cell line HL-60.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2541430      PMCID: PMC287070          DOI: 10.1073/pnas.86.9.3089

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  12 in total

Review 1.  A human retinoic acid receptor which belongs to the family of nuclear receptors.

Authors:  M Petkovich; N J Brand; A Krust; P Chambon
Journal:  Nature       Date:  1987 Dec 3-9       Impact factor: 49.962

Review 2.  An assessment of prediction methods for locating continuous epitopes in proteins.

Authors:  M H Van Regenmortel; G Daney de Marcillac
Journal:  Immunol Lett       Date:  1988-02       Impact factor: 3.685

Review 3.  Effects of vitamin A and its analogs (retinoids) on normal and neoplastic cells.

Authors:  R Lotan
Journal:  Biochim Biophys Acta       Date:  1980-03-12

4.  Differentiation of human promyelocytic HL 60 cells by retinoic acid is accompanied by an increase in the intracellular pH. The role of the Na+/H+ exchange system.

Authors:  A Ladoux; E J Cragoe; B Geny; J P Abita; C Frelin
Journal:  J Biol Chem       Date:  1987-01-15       Impact factor: 5.157

5.  Radioimmunochemical determination of cellular retinol- and cellular retinoic acid-binding proteins in cytosols of rat tissues.

Authors:  D E Ong; J A Crow; F Chytil
Journal:  J Biol Chem       Date:  1982-11-25       Impact factor: 5.157

6.  Expression of granulocytic functions by leukemic promyelocytic HL-60 cells: differential induction by dimethylsulfoxide and retinoic acid.

Authors:  Y Matzner; R Gavison; E A Rachmilewitz; E Fibach
Journal:  Cell Differ       Date:  1987-09

7.  New benzoic acid derivatives with retinoid activity: lack of direct correlation between biological activity and binding to cellular retinoic acid binding protein.

Authors:  A M Jetten; K Anderson; M A Deas; H Kagechika; R Lotan; J I Rearick; K Shudo
Journal:  Cancer Res       Date:  1987-07-01       Impact factor: 12.701

8.  Identification of a second human retinoic acid receptor.

Authors:  N Brand; M Petkovich; A Krust; P Chambon; H de Thé; A Marchio; P Tiollais; A Dejean
Journal:  Nature       Date:  1988-04-28       Impact factor: 49.962

9.  Two signals mediate hormone-dependent nuclear localization of the glucocorticoid receptor.

Authors:  D Picard; K R Yamamoto
Journal:  EMBO J       Date:  1987-11       Impact factor: 11.598

10.  Specific uptake of retinoids into human promyelocytic leukemia cells HL-60 by retinoid-specific binding protein: possibly the true retinoid receptor.

Authors:  Y Hashimoto; H Kagechika; E Kawachi; K Shudo
Journal:  Jpn J Cancer Res       Date:  1988-04
View more
  13 in total

1.  Immunohistochemical localization of renal mineralocorticoid receptor by using an anti-idiotypic antibody that is an internal image of aldosterone.

Authors:  M Lombès; N Farman; M E Oblin; E E Baulieu; J P Bonvalet; B F Erlanger; J M Gasc
Journal:  Proc Natl Acad Sci U S A       Date:  1990-02       Impact factor: 11.205

2.  Effects on differentiation by the promyelocytic leukemia PML/RARalpha protein depend on the fusion of the PML protein dimerization and RARalpha DNA binding domains.

Authors:  F Grignani; U Testa; D Rogaia; P F Ferrucci; P Samoggia; A Pinto; D Aldinucci; V Gelmetti; M Fagioli; M Alcalay; J Seeler; F Grignani; I Nicoletti; C Peschle; P G Pelicci
Journal:  EMBO J       Date:  1996-09-16       Impact factor: 11.598

3.  Immunohistochemical detection of retinoic acid receptor alpha in human skin: a comparison of different fixation protocols.

Authors:  S Epple; M Mittmann; J Reichrath
Journal:  Histochem J       Date:  1996-09

4.  The cellular retinoic acid binding protein I is dispensable.

Authors:  P Gorry; T Lufkin; A Dierich; C Rochette-Egly; D Décimo; P Dollé; M Mark; B Durand; P Chambon
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-13       Impact factor: 11.205

5.  Ligand-dependent occupancy of the retinoic acid receptor beta 2 promoter in vivo.

Authors:  A Dey; S Minucci; K Ozato
Journal:  Mol Cell Biol       Date:  1994-12       Impact factor: 4.272

6.  Characterization of a retinoic acid responsive element isolated by whole genome PCR.

Authors:  M P Costa-Giomi; M P Gaub; P Chambon; P Abarzúa
Journal:  Nucleic Acids Res       Date:  1992-06-25       Impact factor: 16.971

7.  Tumor-suppressive effect of the retinoic acid receptor beta in human epidermoid lung cancer cells.

Authors:  B Houle; C Rochette-Egly; W E Bradley
Journal:  Proc Natl Acad Sci U S A       Date:  1993-02-01       Impact factor: 11.205

8.  A novel retinoic acid-responsive element regulates retinoic acid-induced BLR1 expression.

Authors:  Jianrong Wang; Andrew Yen
Journal:  Mol Cell Biol       Date:  2004-03       Impact factor: 4.272

9.  Covalent modification of proteins by ligands of steroid hormone receptors.

Authors:  N Takahashi; T R Breitman
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-15       Impact factor: 11.205

10.  Exclusive homodimerization of the orphan receptor hepatocyte nuclear factor 4 defines a new subclass of nuclear receptors.

Authors:  G Jiang; L Nepomuceno; K Hopkins; F M Sladek
Journal:  Mol Cell Biol       Date:  1995-09       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.